Details of the Drug

General Information of Drug (ID: DM2WEY1)

Drug Name

BCT-194

Indication

Disease Entry	ICD 11	Status	REF
Psoriasis vulgaris	EA90	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01539915) Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients. U.S. National Institutes of Health.